摘要
目的:探讨增殖诱导配体(APR IL)mRNA在非小细胞肺癌的表达及临床意义。方法:采用荧光定量聚合酶链反应技术检测肺癌组织、癌旁组织及正常肺组织标本中APR IL mRNA的表达情况,其结果与临床病理指标进行分析。结果:APR IL mRNA在肺癌组织中表达最高,癌旁组织次之,正常肺组织最低(P<0.05)。且APR IL mRNA表达水平与肿瘤细胞分化程度、淋巴结远处转移及TNM分期相关(P<0.05),但与患者的性别、年龄、肺癌肿块大小和病理细胞类型无关(P>0.05)。结论:APR IL在肺癌发生和促进其淋巴结远处转移的过程中具有重要功能。
Objective:To explore the expression of APRILmRNA and its clinical significance in nonsmall - cell lung cancer. Methods :Fluorescence quantitative PCR( RFQ- PCR)was used to measure the APRILmRNA expression in the primary tumor tissues, para - cancer tissues and normal tissues, and to analyse their results and results clinical and pathological indexes. Results :APRILmRNA expression level was the highest in the primary tumor tissues compared with the others, followed by para - cancer tissues, with normal tissues last (P 〈 O. 05 ). And APRILmRNA expression level was closely associated with cell differentiation grade,lymph node metastasis and TNM stage of nonsmall -cell lung cancer( P 〈 0. 05 ), but not with the tumour size,the pathological cell types or gender and age of patients ( P 〉 0. 05 ). Conclusion : APRIL plays an important role in the malignant progression and lymph node metastasis of nonsmall - cell lung cancer.
出处
《南通大学学报(医学版)》
2006年第3期186-188,共3页
Journal of Nantong University(Medical sciences)
关键词
非小细胞肺癌
聚合酶链反应
增殖诱导配体
Nonsmall -cell lung cancer
Polymerase Chain Reaction
A proliferation - inducing ligand